Immunophenotype predicts outcome in pediatric acute liver failure

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 3, 2013, Pages 311-315

  Bucuvalas, John ^a   Filipovich, Lisa ^a   Yazigi, Nada ^a   Narkewicz, Michael R ^b   Ng, Vicky ^c   Belle, Steven H ^d   Zhang, Song ^d   Squires, Robert H ^e  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Hospital for Sick Children ^*  (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

acute liver failure; immune activation; outcome; sIL2R

Indexed keywords

SOLUBLE INTERLEUKIN 2 RECEPTOR; SOLUBLE INTERLEUKIN 2 RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ARTICLE; CHILD; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LIVER FAILURE, ACUTE; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; MALE; PROGNOSIS; SOLUBILITY; SURVIVAL ANALYSIS; T-LYMPHOCYTES; UP-REGULATION;

EID: 84874949735     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31827a78b2     Document Type: Article

References (23)

1. Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652-8
2. Dhiman RK, Seth AK, Jain S, et al. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998;43:1311-6
3. Liu E, MacKenzie T, Dobyns EL, et al. Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol 2006;44:134-41
4. Lu BR, Gralla J, Liu E, et al. Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol 2008;6:1140-5
5. Pelaez-Luna M, Martinez-Salgado J, Olivera-Martinez MA. Utility of the MAYO End-Stage Liver Disease score, King's College Criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transplant Proc 2006;38:927-9
6. Rhee C, Narsinh K, Venick RS, et al. Predictors of clinical outcome in children undergoing orthotopic liver transplantation for acute and chronic liver disease. Liver Transpl 2006;12:1347-56
7. Sindhi R, Soltys K, Bond G, et al. PELD allocation and acute liver/graft failure. Liver Transpl 2007;13:776-7
8. Katoonizadeh A, Decaestecker J, Wilmer A, et al. MELD score to predict outcome in adult patients with non-Acetaminophen-induced acute liver failure. Liver Int 2007;27:329-34
9. Polson J, Lee WM. AASLD position paper: The management of acute liver failure. Hepatology 2005;41:1179-97
10. Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000;6:163-9
11. Yazigi N, Tial G, Filipovich A, et al. Natural killer dysfunction in pediatric acute liver failure. Am J Transplant 2008;8 (supp s2):327A.
12. Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32 (4 Pt 1): 734-9
13. Filipovich AH. Life-Threatening hemophagocytic syndromes: Current outcomes with hematopoietic stem cell transplantation. Pediatr Transplant 2005;9 (suppl 7):87-91
14. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31
15. Kogawa K, Lee SM, Villanueva J, et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002;99:61-6
16. Sullivan KE, Delaat CA, Douglas SD, et al. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 1998;44:465-8
17. Filipovich AH. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am 2008;28:293-313
18. Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 2005;41:26-31
19. Schiodt FV, Ostapowicz G, Murray N, et al. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006;12:1776-81
20. Zheng YB, Gao ZL, Zhong F, et al. Predictive value of serum-soluble CD154 in fulminant hepatic failure. J Int Med Res 2008;36:728-33
21. Ilonen I, Koivusalo AM, Repo H, et al. Cytokine profiles in acute liver failure treated with albumin dialysis. Artif Organs 2008;32:52-60
22. Rudnick DA, Dietzen DJ, Turmelle YP, et al. Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant 2009;13:223-30
23. Mi Q, Li NY, Ziraldo C, et al. Translational systems biology of inflammation: Potential applications to personalized medicine. Per Med 2010;7:549-59